Levoleucovorin Calcium Patent Expiration
Levoleucovorin Calcium was first introduced by Acrotech Biopharma Inc
Levoleucovorin Calcium Patents
Given below is the list of patents protecting Levoleucovorin Calcium, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Fusilev | US6500829 | Substantially pure diastereoisomers of tetrahydrofolate derivatives |
Mar 07, 2022
(Expired) | Acrotech Biopharma |
Coming Soon
Patent Strength Analyzer
![](/_nuxt/img/PatentAnalyzerAd.722976d.jpg)
YesNo
Thank you for your response 🥳
Levoleucovorin Calcium Generics
Several generic applications have been filed for Levoleucovorin Calcium. The first generic version for Levoleucovorin Calcium was by Sandoz Inc and was approved on Mar 9, 2015. And the latest generic version is by Hainan Poly Pharmaceutical Co Ltd and was approved on May 22, 2023.
Given below is the list of companies who have filed for Levoleucovorin Calcium generic.
1. HAINAN POLY PHARM
Hainan Poly Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Levoleucovorin Calcium. Given below are the details of the strengths of this generic introduced by Hainan Poly Pharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | May 22, 2023 |
EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | May 22, 2023 |
2. AMNEAL
Amneal Eu Ltd has filed for 2 different strengths of generic version for Levoleucovorin Calcium. Given below are the details of the strengths of this generic introduced by Amneal.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | powder | Discontinued | INTRAVENOUS | N/A | Feb 13, 2017 |
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | Sep 8, 2017 |
3. ACTAVIS LLC
Actavis Llc has filed for 1 generic for Levoleucovorin Calcium. Given below are the details of the strengths of this generic introduced by Actavis Llc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | powder | Discontinued | INTRAVENOUS | N/A | Feb 13, 2017 |
4. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Levoleucovorin Calcium. Given below are the details of the strengths of this generic introduced by Hikma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | powder | Discontinued | INTRAVENOUS | N/A | Jun 16, 2016 |
5. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 2 different strengths of generic version for Levoleucovorin Calcium. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 250MG BASE/25ML (EQ 10MG BASE/ML)
(reference standard) | solution | Prescription | INTRAVENOUS | AP | Sep 14, 2018 |
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | Sep 14, 2018 |
6. SANDOZ
Sandoz Inc has filed for 2 different strengths of generic version for Levoleucovorin Calcium. Given below are the details of the strengths of this generic introduced by Sandoz.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | Mar 9, 2015 |
EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | solution | Discontinued | INTRAVENOUS | N/A | Mar 9, 2015 |
7. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 2 different strengths of generic version for Levoleucovorin Calcium. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | solution | Discontinued | INTRAVENOUS | N/A | Oct 20, 2015 |
EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | solution | Discontinued | INTRAVENOUS | N/A | Oct 20, 2015 |
8. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 3 different strengths of generic version for Levoleucovorin Calcium. Given below are the details of the strengths of this generic introduced by Meitheal.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML)
(reference standard) | solution | Prescription | INTRAVENOUS | AP | Aug 16, 2019 |
EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | solution | Discontinued | INTRAVENOUS | N/A | Aug 16, 2019 |
EQ 50MG BASE/VIAL | powder | Discontinued | INTRAVENOUS | N/A | Aug 22, 2019 |
9. AILEX PHARMS LLC
Ailex Pharmaceuticals Llc has filed for 1 generic for Levoleucovorin Calcium. Given below are the details of the strengths of this generic introduced by Ailex Pharms Llc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | solution | Discontinued | INTRAVENOUS | N/A | Nov 2, 2021 |
10. NOVAST LABS
Novast Laboratories Ltd has filed for 2 different strengths of generic version for Levoleucovorin Calcium. Given below are the details of the strengths of this generic introduced by Novast Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) | solution | Discontinued | INTRAVENOUS | N/A | May 3, 2018 |
EQ 250MG BASE/25ML (EQ 10MG BASE/ML) | solution | Discontinued | INTRAVENOUS | N/A | May 3, 2018 |